Dupilumab may provide a nonsteroidal option for managing cancer therapy-related skin toxicities, according to a study.

Over the past 20 years, a class of cancer drugs called CD40 agonist antibodies have shown great promise—and induced great ...

The Breast Cancer Research Foundation, or BCRF, has named Ulta Beauty chief executive officer Kecia Steelman to its board.

Dallas Cowboys owner Jerry Jones reveals PD-1 therapy saved his life after a 2010 stage 4 melanoma diagnosis and now has 'no ...

Researchers demonstrate that an engineered antibody improves a class of drugs that has struggled to make good on its early promise.

MiNK Therapeutics(NASDAQ:INKT) reported its fiscal second quarter ended June 30, 2025, on Aug. 14, 2025, posting a $4.2 million net loss and announcing a $13 million equity raise after quarter-end, ...

Superior double-stranded DNA (dsDNA) recovery rates versus other technologies, reducing sequencing requirements by 10- to 100-fold to achieve ultrasensitive detection levels and enabling a ...

People who are allergic may suffer hives, itchy skin, a rash or, in severe cases, a potentially life-threatening reaction known as anaphylaxis upon exposure.

Q2 2025 Management View Jennifer S. Buell, President and CEO, stated that MiNK continues to be "the most clinically advanced company, industrializing off-the-shelf, invariant natural killer T cells." ...